What is NDC 60505-6287?

60505-6287 is the product NDC for Oxaliplatin, Oxaliplatin 5 mg/mL injection, solution, listed with the FDA by Apotex Corp.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Oxaliplatin?

39 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Oxaliplatin NDC 60505-6287 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)60505-6287Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60505-6287Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60505-6287-2	6050562870260505628702	1 VIAL in 1 CARTON (60505-6287-2) / 10 mL in 1 VIALMarketed from Apr 23, 2024
60505-6287-4	6050562870460505628704	1 VIAL in 1 CARTON (60505-6287-4) / 20 mL in 1 VIALMarketed from Apr 23, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oxaliplatin
Generic name (nonproprietary): oxaliplatin
Active ingredients: Oxaliplatin — 5 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Apotex Corp.NDC labeler code 60505
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204368
Marketing start: Apr 23, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Platinum-containing Compounds (EXT)
Identifiers: Product ID 60505-6287_e56ed9d9-cd5b-4ba2-82a3-eb805fbc1a5bSPL ID e56ed9d9-cd5b-4ba2-82a3-eb805fbc1a5bSPL set ID bb180ec5-1f75-43c1-9f63-c0657af2ca5fRxCUI 1736776, 1736781UNII 04ZR38536J
Pharmacologic class: Platinum-based Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N460505628702 followed by a unit qualifier and the quantity

Package 60505-6287-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 4, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Oxaliplatin Injection USP, in combination with infusional fluorouracil and leucovorin, is indicated for: adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor. treatment of advanced colorectal cancer. Oxaliplatin Injection USP is a platinum-based drug used in combination with infusional fluorouracil and leucovorin, which is indicated for: adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor. ( 1 ) treatment of advanced colorectal cancer. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60505-6287

What is NDC 60505-6287?: 60505-6287 is the product NDC for Oxaliplatin, Oxaliplatin 5 mg/mL injection, solution, listed with the FDA by Apotex Corp.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Oxaliplatin.
What is the active ingredient?: Oxaliplatin.
Who is the labeler?: Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Oxaliplatin?: 39 other product NDCs are listed under this name. See all Oxaliplatin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Oxaliplatin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
oxaliplatin	Oxaliplatin 5 mg/mL	Injection, SolutionIntravenous	Shandong New Time Pharmaceutical Co., Ltd.	42677-336	42677-0336-10
oxaliplatin	Oxaliplatin 5 mg/mL	Injection, SolutionIntravenous	Shandong New Time Pharmaceutical Co., Ltd.	42677-337	42677-0337-10
Oxaliplatin	Oxaliplatin 50 mg/10mL	Injection, Solution, ConcentrateIntravenous	Camber Pharmaceuticals, Inc.	31722-357	31722-0357-10
Oxaliplatin	Oxaliplatin 100 mg/20mL	Injection, Solution, ConcentrateIntravenous	Camber Pharmaceuticals, Inc.	31722-358	31722-0358-20
Oxaliplatin	Oxaliplatin 5 mg/mL	Injection, SolutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-171	71288-0171-11
Oxaliplatin	Oxaliplatin 5 mg/mL	Injection, SolutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-172	71288-0172-21
Oxaliplatin	Oxaliplatin 5 mg/mL	Injection, SolutionIntravenous	Northstar Rx LLC	72603-320	72603-0320-01
Oxaliplatin	Oxaliplatin 5 mg/mL	Injection, SolutionIntravenous	Northstar Rx LLC	72603-420	72603-0420-01
Oxaliplatin	Oxaliplatin 5 mg/mL	Injection, SolutionIntravenous	BluePoint Laboratories	68001-468	68001-0468-3668001-0468-37
Oxaliplatin	Oxaliplatin 5 mg/mL	Injection, SolutionIntravenous	FOSUN PHARMA USA INC.	72266-161	72266-0161-01

All 40 Oxaliplatin NDCs

Other NDCs under ANDA 204368

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204368
Product	Strength	Form · route	Labeler	Product NDC
Oxaliplatin	Oxaliplatin 5 mg/mL	Injection, SolutionIntravenous	Apotex Corp.	60505-6132
Oxaliplatin	Oxaliplatin 50 mg/10mL	Injection, SolutionIntravenous	Qilu Pharmaceutical Co., Ltd.	67184-0508
Oxaliplatin	Oxaliplatin 100 mg/20mL	Injection, SolutionIntravenous	Qilu Pharmaceutical Co., Ltd.	67184-0509
Oxaliplatin	Oxaliplatin 200 mg/40mL	Injection, SolutionIntravenous	Qilu Pharmaceutical Co., Ltd.	67184-0510
Oxaliplatin	Oxaliplatin 5 mg/mL	Injection, SolutionIntravenous	BluePoint Laboratories	68001-468